Fernando Fernández-García

3PUBLICATIONS
23CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 26, 2024
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.

Fernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre

|Jul 24, 2021
KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform.

Marina Salmón, Guillem Paniagua, Carmen G Lechuga

|Sep 11, 2020
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.

Laura Esteban-Burgos, Haiyun Wang, Patricia Nieto

Pageof 1